Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells
Citations Over TimeTop 10% of 2015 papers
Abstract
Recent studies show that long non-coding RNAs (lncRNAs) may be significant functional regulators in tumor development, including bladder cancer. Here, we found that PVT1 was upregulated in bladder cancer tissues and cells. Further experiments revealed that PVT1 promoted cell proliferation and suppressed cell apoptosis. Furthermore we also used the emerging technology, synthetic biology, to create tetracycline-inducible small hairpin RNA (shRNA) vectors which silenced PVT1 in a dosage-dependent manner to inhibit the progression of bladder cancer. In conclusion, data suggest that PVT1 could be an oncogene and may be a therapeutic target in bladder cancer. Synthetic "tetracycline-on" switch system can be used to quantitatively control the expression of PVT1 in bladder cancer in response to different concentration of doxycycline to suppress the progression of bladder cancer.
Related Papers
- → siRNA vs. shRNA: Similarities and differences(2009)637 cited
- → Transgenic RNA Interference in Mice(2007)37 cited
- → RNA Interference in Mice(2007)28 cited
- Knockdown of Human p53 Gene Expression in 293-T Cells by Retroviral Vector-mediated Short Hairpin RNA(2005)
- → Ανάπτυξη φορέων τύπου spuma που εκφράζουν anti-α-σφαιρίνης short hairpin RNA (shRNA)(2011)